Skip to main content
Premium Trial:

Request an Annual Quote

Xenomics Changes Name to TrovaGene

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – San Diego-based Xenomics has changed its name to TrovaGene and its ticker symbol to TROV, effective yesterday.

The firm is developing molecular diagnostics based on its transrenal nucleic acid technology. TrovaGene said that it has leased a 5000-square-foot facility in the Sorrento Valley area of San Diego and is in the process of completing all the necessary laboratory validations. The firm added that it plans to expand its scientific team as it works toward becoming a fully integrated diagnostic business by the end of the second quarter of this year.

Among the products TrovaGene has in development are a KRAS assay and an assay for human papillomavirus genotypes.

TrovaGene's shares currently trade at $.59 on the Pink Sheets.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.